Role of hTERT rs2736100 in pathological scarring
Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family histor...
Saved in:
Published in: | Experimental and therapeutic medicine Vol. 23; no. 4 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Athens
Spandidos Publications
01-04-2022
Spandidos Publications UK Ltd D.A. Spandidos |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/[m.sup.2] was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section. Key words: hTERT, single nucleotide polymorphism, hypertrophic scar, atrophic scar, RT-PCR |
---|---|
AbstractList | Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/[m.sup.2] was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section. Key words: hTERT, single nucleotide polymorphism, hypertrophic scar, atrophic scar, RT-PCR Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase ( hTERT ) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/m 2 was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section. Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/m2 was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section. Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/[m.sup.2] was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section. |
ArticleNumber | 260 |
Audience | Academic |
Author | Ilies, Roxana Flavia Catana, Andreea Lukacs, Istvan Tokes, Reka- Eniko Rotar, Ioana Cristina Halmagyi, Salomea-Ruth Pop, Ioan Victor Aioanei, Casian Simon |
AuthorAffiliation | 1 Department of Medical Genetics, ‘Iuliu Hațieganu’ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 2 Department of Oncogenetics, ‘Ion Chiricuță’ Oncological Institute, 400015 Cluj-Napoca, Romania 3 1st Department of Obstetrics and Gynecology, ‘Iuliu Hațieganu’ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 4 1st Clinic of Obstetrics and Gynecology, Emergency County Hospital, 400006 Cluj-Napoca, Romania |
AuthorAffiliation_xml | – name: 1 Department of Medical Genetics, ‘Iuliu Hațieganu’ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania – name: 3 1st Department of Obstetrics and Gynecology, ‘Iuliu Hațieganu’ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania – name: 2 Department of Oncogenetics, ‘Ion Chiricuță’ Oncological Institute, 400015 Cluj-Napoca, Romania – name: 4 1st Clinic of Obstetrics and Gynecology, Emergency County Hospital, 400006 Cluj-Napoca, Romania |
Author_xml | – sequence: 1 fullname: Ilies, Roxana Flavia – sequence: 2 fullname: Halmagyi, Salomea-Ruth – sequence: 3 fullname: Catana, Andreea – sequence: 4 fullname: Aioanei, Casian Simon – sequence: 5 fullname: Lukacs, Istvan – sequence: 6 fullname: Tokes, Reka- Eniko – sequence: 7 fullname: Rotar, Ioana Cristina – sequence: 8 fullname: Pop, Ioan Victor |
BookMark | eNptkc1LAzEQxYMoVqtXzwueu04myW72IhTxCwSh1HPIZrNtZHdTk63gf2_UUhCaOSTM_ObxyDsnx4MfLCFXFHImK7yxY58jIOaUUlkckTNaVjijQMXx7g2VpBNyGeM7pCMKKqU4JRMmUFCGxRmBhe9s5ttsvbxfLLMQsWQFBcjckG30uPadXzmjuywaHYIbVhfkpNVdtJe7e0reHu6Xd0-zl9fH57v5y8xwKsZZqznXgJzJGqsWQTYUGceKiSpZN8h5gzLNsWbIaqihMbySBaemNZIlbkpu_3Q327q3jbHDGHSnNsH1Onwpr536PxncWq38p5LpZwpkSeB6JxD8x9bGUb37bRiSZ4UF52UBkLA9tdKdVW5ofRIzvYtGzUuACgWIMlH5ASpVY3tnUiitS_1DCyb4GINt98YpqJ_sVMpO_WSnfrNj3zB-h0k |
CitedBy_id | crossref_primary_10_1007_s13167_022_00309_x |
Cites_doi | 10.1007/s00238-011-0661-3 10.3109/14764172.2010.514924 10.1111/j.1600-0846.2008.00327.x 10.2119/molmed.2009.00153 10.1111/ddg.13027_g 10.1111/wrr.12302 10.1007/s00403-009-1014-y 10.1111/bjd.13826 10.1097/01.ta.0000108997.49513.dc 10.1016/j.jisp.2016.10.024 10.1016/j.bjps.2015.11.015 10.3892/etm.2019.7513 10.1186/1471-2350-10-110 10.1097/DAD.0b013e31825ba13f 10.1097/MCO.0b013e32834121b1 10.1186/s12929-018-0422-8 10.1001/archderm.124.6.869 10.1371/journal.pone.0097114 10.1016/j.burns.2005.01.022 10.1016/j.yexcr.2016.05.013 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 Spandidos Publications Copyright Spandidos Publications UK Ltd. 2022 Copyright © 2020, Spandidos Publications 2020 |
Copyright_xml | – notice: COPYRIGHT 2022 Spandidos Publications – notice: Copyright Spandidos Publications UK Ltd. 2022 – notice: Copyright © 2020, Spandidos Publications 2020 |
DBID | AAYXX CITATION 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. KB0 M0S NAPCQ PQEST PQQKQ PQUKI PRINS 5PM |
DOI | 10.3892/etm.2022.11186 |
DatabaseName | CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) British Nursing Index with Full Text ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest One Academic Eastern Edition |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1792-1015 |
ExternalDocumentID | A700925057 10_3892_etm_2022_11186 |
GeographicLocations | Romania |
GeographicLocations_xml | – name: Romania |
GroupedDBID | --- 0R~ 3V. 53G 7RV 7X7 8FI 8FJ AAKDD AAYXX ABDBF ABJNI ABUWG ACGFS ADBBV AENEX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CCPQU CITATION EBD EBS EJD ESX F5P FYUFA H13 HMCUK HUR HZ~ IAO IHR IPNFZ ITC NAPCQ O9- OK1 OVD PQQKQ PROAC RIG RPM TEORI UKHRP 7XB 8FK K9. PQEST PQUKI PRINS 5PM |
ID | FETCH-LOGICAL-c415t-fa44a02438b29f208d123429359389c244d280242b323b0b0dc498641cfc83293 |
IEDL.DBID | RPM |
ISSN | 1792-0981 |
IngestDate | Tue Sep 17 20:46:31 EDT 2024 Thu Oct 10 15:20:40 EDT 2024 Tue Nov 19 21:22:38 EST 2024 Tue Nov 12 23:28:44 EST 2024 Fri Aug 23 03:06:32 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c415t-fa44a02438b29f208d123429359389c244d280242b323b0b0dc498641cfc83293 |
Notes | Abbreviations: SNP, single nucleotide polymorphism; POSAS, Patient Observer Scar Assessment Scale; RT-PCR, real-time polymerase chain reaction Contributed equally |
OpenAccessLink | https://www.spandidos-publications.com/10.3892/etm.2022.11186/download |
PMID | 35251326 |
PQID | 2644760062 |
PQPubID | 2044959 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8892623 proquest_journals_2644760062 gale_infotracmisc_A700925057 gale_infotracacademiconefile_A700925057 crossref_primary_10_3892_etm_2022_11186 |
PublicationCentury | 2000 |
PublicationDate | 2022-04-01 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Athens |
PublicationPlace_xml | – name: Athens |
PublicationTitle | Experimental and therapeutic medicine |
PublicationYear | 2022 |
Publisher | Spandidos Publications Spandidos Publications UK Ltd D.A. Spandidos |
Publisher_xml | – name: Spandidos Publications – name: Spandidos Publications UK Ltd – name: D.A. Spandidos |
References | Butzelaar (key20220330120639_b19-ETM-0-0-11186) 2016; 69 Deliaert (key20220330120639_b20-ETM-0-0-11186) 2012; 35 De Felice (key20220330120639_b12-ETM-0-0-11186) 2009; 10 Li (key20220330120639_b15-ETM-0-0-11186) 2016; 345 Leão (key20220330120639_b17-ETM-0-0-11186) 2018; 25 Shih (key20220330120639_b6-ETM-0-0-11186) 2010; 302 Poetschke (key20220330120639_b21-ETM-0-0-11186) 2016; 14 Scrimali (key20220330120639_b3-ETM-0-0-11186) 2010; 12 Ilie (key20220330120639_b2-ETM-0-0-11186) 2019; 18 Butzelaar (key20220330120639_b18-ETM-0-0-11186) 2015; 23 Huang (key20220330120639_b8-ETM-0-0-11186) 2013; 35 Fitzpatrick (key20220330120639_b13-ETM-0-0-11186) 1988; 124 Gozali (key20220330120639_b5-ETM-0-0-11186) 2015; 8 Shammas (key20220330120639_b10-ETM-0-0-11186) 2011; 14 Li-Tsang (key20220330120639_b4-ETM-0-0-11186) 2005; 31 Gauglitz (key20220330120639_b1-ETM-0-0-11186) 2011; 17 Kiprono (key20220330120639_b16-ETM-0-0-11186) 2015; 173 Zhu (key20220330120639_b11-ETM-0-0-11186) 2014; 9 Glass (key20220330120639_b7-ETM-0-0-11186) 2017; 18 (Suppl) Idriss (key20220330120639_b14-ETM-0-0-11186) 2009; 15 Wu (key20220330120639_b9-ETM-0-0-11186) 2004; 57 |
References_xml | – volume: 35 start-page: 421 year: 2012 ident: key20220330120639_b20-ETM-0-0-11186 article-title: Smoking and its effect on scar healing publication-title: Eur J Plast Surg doi: 10.1007/s00238-011-0661-3 contributor: fullname: Deliaert – volume: 12 start-page: 218 year: 2010 ident: key20220330120639_b3-ETM-0-0-11186 article-title: Treatment of hypertrophic scars and keloids with a fractional CO2 laser: A personal experience publication-title: J Cosmet Laser Ther doi: 10.3109/14764172.2010.514924 contributor: fullname: Scrimali – volume: 15 start-page: 1 year: 2009 ident: key20220330120639_b14-ETM-0-0-11186 article-title: Scar assessment scales: A dermatologic overview publication-title: Ski Res Technol doi: 10.1111/j.1600-0846.2008.00327.x contributor: fullname: Idriss – volume: 17 start-page: 113 year: 2011 ident: key20220330120639_b1-ETM-0-0-11186 article-title: Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies publication-title: Mol Med doi: 10.2119/molmed.2009.00153 contributor: fullname: Gauglitz – volume: 14 start-page: 467 year: 2016 ident: key20220330120639_b21-ETM-0-0-11186 article-title: Aktuelle optionen zur behandlung pathologischer Narben publication-title: J Dtsch Dermatol Ges doi: 10.1111/ddg.13027_g contributor: fullname: Poetschke – volume: 23 start-page: 531 year: 2015 ident: key20220330120639_b18-ETM-0-0-11186 article-title: Going into surgery: Risk factors for hypertrophic scarring publication-title: Wound Repair Regen doi: 10.1111/wrr.12302 contributor: fullname: Butzelaar – volume: 302 start-page: 319 year: 2010 ident: key20220330120639_b6-ETM-0-0-11186 article-title: Genetics of keloid scarring publication-title: Arch Dermatol Res doi: 10.1007/s00403-009-1014-y contributor: fullname: Shih – volume: 173 start-page: 852 year: 2015 ident: key20220330120639_b16-ETM-0-0-11186 article-title: Epidemiology of keloids in normally pigmented Africans and African people with albinism: Population-based cross-sectional survey publication-title: Br J Dermatol doi: 10.1111/bjd.13826 contributor: fullname: Kiprono – volume: 57 start-page: 1276 year: 2004 ident: key20220330120639_b9-ETM-0-0-11186 article-title: Gene expression of early hypertrophic scar tissue screened by means of cDNA microarrays publication-title: J Trauma doi: 10.1097/01.ta.0000108997.49513.dc contributor: fullname: Wu – volume: 18 (Suppl) start-page: S50 year: 2017 ident: key20220330120639_b7-ETM-0-0-11186 article-title: Current understanding of the genetic causes of keloid formation publication-title: J Investig Dermatology Symp Proc doi: 10.1016/j.jisp.2016.10.024 contributor: fullname: Glass – volume: 69 start-page: 163 year: 2016 ident: key20220330120639_b19-ETM-0-0-11186 article-title: Currently known risk factors for hypertrophic skin scarring: A review publication-title: J Plast Reconstr Aesthetic Surg doi: 10.1016/j.bjps.2015.11.015 contributor: fullname: Butzelaar – volume: 18 start-page: 916 year: 2019 ident: key20220330120639_b2-ETM-0-0-11186 article-title: Capsaicin: Physicochemical properties, cutaneous reactions and potential applications in painful and inflammatory conditions (Review) publication-title: Exp Ther Med doi: 10.3892/etm.2019.7513 contributor: fullname: Ilie – volume: 10 issue: 110 year: 2009 ident: key20220330120639_b12-ETM-0-0-11186 article-title: Telomere shortening may be associated with human keloids publication-title: BMC Med Genet doi: 10.1186/1471-2350-10-110 contributor: fullname: De Felice – volume: 8 start-page: 33 year: 2015 ident: key20220330120639_b5-ETM-0-0-11186 article-title: Effective treatments of atrophic acne scars publication-title: J Clin Aesthet Dermatol contributor: fullname: Gozali – volume: 35 start-page: 64 year: 2013 ident: key20220330120639_b8-ETM-0-0-11186 article-title: A snapshot of gene expression signatures generated using microarray datasets associated with excessive scarring publication-title: Am J Dermatopathol doi: 10.1097/DAD.0b013e31825ba13f contributor: fullname: Huang – volume: 14 start-page: 28 year: 2011 ident: key20220330120639_b10-ETM-0-0-11186 article-title: Telomeres, lifestyle, cancer, and aging publication-title: Curr Opin Clin Nutr Metab Care doi: 10.1097/MCO.0b013e32834121b1 contributor: fullname: Shammas – volume: 25 issue: 22 year: 2018 ident: key20220330120639_b17-ETM-0-0-11186 article-title: Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: Clinical impacts in cancer publication-title: J Biomed Sci doi: 10.1186/s12929-018-0422-8 contributor: fullname: Leão – volume: 124 start-page: 869 year: 1988 ident: key20220330120639_b13-ETM-0-0-11186 article-title: The validity and practicality of sun-reactive skin types I through VI publication-title: Arch Dermatol doi: 10.1001/archderm.124.6.869 contributor: fullname: Fitzpatrick – volume: 9 issue: e97114 year: 2014 ident: key20220330120639_b11-ETM-0-0-11186 article-title: MicroRNA-21 regulates hTERT via PTEN in hypertrophic scar fibroblasts publication-title: PLoS One doi: 10.1371/journal.pone.0097114 contributor: fullname: Zhu – volume: 31 start-page: 610 year: 2005 ident: key20220330120639_b4-ETM-0-0-11186 article-title: Prevalence of hypertrophic scar formation and its characteristics among the Chinese population publication-title: Burns doi: 10.1016/j.burns.2005.01.022 contributor: fullname: Li-Tsang – volume: 345 start-page: 93 year: 2016 ident: key20220330120639_b15-ETM-0-0-11186 article-title: Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2016.05.013 contributor: fullname: Li |
SSID | ssj0000561885 |
Score | 2.288998 |
Snippet | Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has... |
SourceID | pubmedcentral proquest gale crossref |
SourceType | Open Access Repository Aggregation Database |
SubjectTerms | Cicatrices Comparative analysis Development and progression Family medical history Fibroblasts Genetic aspects Genotype & phenotype Health aspects Inflammation Overweight Patients Physiology Risk factors Scars Single nucleotide polymorphisms Software Telomerase White people Wound healing |
Title | Role of hTERT rs2736100 in pathological scarring |
URI | https://www.proquest.com/docview/2644760062 https://pubmed.ncbi.nlm.nih.gov/PMC8892623 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ07b8IwEICtwtSl6lOlpZWHii4EjGPAGREFsbRCLZW6WbaJBRIERGDg3_cuj0IYO8dR7PPZd-ecvyPkBeNp7XzjBb41HvJKPG1M4PGQhYFxMnTJgf7oq_vxI98GiMlp53dhkqR9a-aNaLFsRPNZklu5XtpmnifWHL_3pUTKnd8skRL4hkchegr07rRkUooTdI17LJCtFNYIppk3wy1eP-cctwqJ9YsQBwoRWadgl05359OMySMTNLwkF5nvSHtpH6_IWRhdk9o4hU_v63RyuEsV12mNjg9Y6v0NYZ-rRUhXjs7Ag53QTQwuBXg1jM4jinWJ812QxlZv8LTvlnwPB5P-yMvqJXgWzPDWc1oIjYRBaXjgOJNTMEtgb_x2AGO3YMinXKJNNj73DTNsagXS2VvWWVjYgX9HytEqCu8JFeBFaSORDqZFV8DuLALBdMsx7bs2ExXymktLrVMshoJwAkWsQMQKRawSEUNLFKbC9QKiszpL-4fvIHlK9bqIfcIwqUKqhZag57b4OJ8Ola2zWKE7h78WO7xCuoUp-usW8rOLT0CtEo52pkYP_37zkZzjQNNEniopbze78ImU4unuOdHJX1GQ4ZA |
link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xHODCjiirDwguhLqO2zpHVIqKWFRBkbhZthuLSjStmnLg75nJAoQjZzuK4-fZnJk3AKcUTxsf2iAKnQ2IryQw1kaBiHkcWa9in13o957bj6_quks0Oc2yFiZL2nd2dJm8jy-T0VuWWzkdu3qZJ1bvP3SUIpa7sL4IyyivnP8K0nNK71ZDZc048bSJgEeqkdM1onEW9XhOBehCkLJQ1MGICEExJmtVLNNf_fw3Z_KXEbpZ_-fyN2Ct8DrZVT68CQtxsgVn_Zy2-vOCDX6qsNILdsb6P4TWn9vAnybvMZt49oa-74DNUnRG0B_ibJQw6mhc6k-WOjOje8IdeLnpDjq9oOi0EDg04PPAGykNcRMqKyIvuBqiQUNLFTYj3DOHLsBQKLLmNhSh5ZYPnSRe94bzDlVCFO7CUjJJ4j1gEv0vYxXxihnZlqjXZSS5aXhuQt_ksgbn5S7raU6ooTEQIWg0QqMJGp1BgzMJBE2ShlvuTFEwgO8hzip91SbCKAqwanBYmYkS4qrDJYy6kNBUkyNIPyVbogbtCrTfyyLm7eoIIpoxcBcI7v_7yRNY6Q0e7vX97ePdAazSR-fpQIewNJ99xEewmA4_jrNz_QXLhvce |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3JTsMwEIZHLBLiwo4oqw8ILoS4jmmdIwIqEIsqKBI3y3ZitRKkVVMOvD0zSQqEI5zjKIn_eJZk_A3AIeXTxkc2iCNnA-KVBMbaOBApT2PrVeqLD_rXT-2HF3V5RZicr1ZfRdG-s4PT7PXtNBv0i9rK0ZsLp3ViYff-Qimi3EXhKPHhLMzjmuXiR6JeYr1bTVU05MQ3TgQ8Vs0S2YgOWoTphDahC0EGQ1EXI4KCYl7Wqnmn3zb6d93kD0fUWf7HI6zAUhV9svNyyCrMpNkaHHVLfPXHCet978bKT9gR636DrT_WgT8OX1M29KyPMXCPjXMMSjAu4myQMepsPLWjLHdmTN8LN-C5c9W7uA6qjguBQ0c-CbyR0hCjUFkRe8FVgo4NPVZ0FuO8OQwFEqHIq9tIRJZbnjhJfPem8w5NQxxtwlw2zNItYBLjMGMV8cWMbEu07zKW3DQ9N5E_47IBx9OZ1qMSrKExISF5NMqjSR5dyIMjSQhNKw6n3Zlq4wBeh9hV-rxN4ChKtBqwWxuJK8XVD0-l1NVKzTUFhPRzsiUa0K7J-3VbROCuH0FVCxJ3peL2n888gIXuZUff3Tzc7sAiPXNZFbQLc5Pxe7oHs3nyvl-82p_Jzfme |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+hTERT+rs2736100+in+pathological+scarring&rft.jtitle=Experimental+and+therapeutic+medicine&rft.au=Halmagyi%2C+Salomea-Ruth&rft.au=C%C4%83tan%C4%83%2C+Andreea&rft.au=Aioanei%2C+Casian+Simon&rft.au=Lukacs%2C+Istvan&rft.date=2022-04-01&rft.pub=Spandidos+Publications+UK+Ltd&rft.issn=1792-0981&rft.eissn=1792-1015&rft.volume=23&rft.issue=4&rft_id=info:doi/10.3892%2Fetm.2022.11186&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-0981&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-0981&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-0981&client=summon |